Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
0
Participant gender:
All
Summary
This study is designed to evaluate if nelfinavir works as a radiation sensitizer in
combination with gemcitabine (a chemotherapy). We are also looking to establish the maximum
dose of gemcitabine that is tolerated with the nelfinavir and radiation therapy, so the dose
of gemcitabine is increased based on how previous trial participants tolerated their dose of
gemcitabine.